Skip to content

Effect of dexmedetomidine hydrochloride nasal spray on postoperative sleep of patients undergoing video-assisted thoracoscopic surgery

Effect of dexmedetomidine hydrochloride nasal spray on postoperative sleep of patients undergoing video-assisted thoracoscopic surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099569
Enrollment
Unknown
Registered
2025-03-25
Start date
2025-03-26
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodules

Interventions

2.0 µ g/kg dexmedetomidine hydrochloride nasal spray:2.0 µ g/kg nasal spray dexmedetomidine was administered from 21:00 to 21:30 on the night before surgery, the first day and the second day after sur
1.0 µ g/kg dexmedetomidine hydrochloride nasal spray:1.0 µ g/kg nasal spray dexmedetomidine was administered from 21:00 to 21:30 on the night before surgery, the first day and the second day after sur
Normal saline group:1.0 µ g/kg nasal spray normal saline was administered from 21:00 to 21:30 on the night before operation, the first day and the second day after operation

Sponsors

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1 Age range: 18-65 years old, gender not limited; 2 ASA levels I-III; 3 Electively perform VATS (wedge resection of lung lobes, segments, and lungs).

Exclusion criteria

Exclusion criteria: 1 Unilateral total lung resection; 2 Patients with sleep apnea syndrome; 3 Those who are allergic to any drugs used in this test; 4 Patients with hypotension, bradycardia and sinus arrest; 5 People with previous history of allergic rhinitis, nasal surgery and history of respiratory tract infection within the last 2 weeks; 6 Those with severe liver and kidney function abnormalities; 7 Those who have been taking sedative-hypnotic drugs for a long time (>3 months); 8 Those who are dependent on alcohol; 9 Those who are unable to communicate normally: hearing impairment, language comprehension disorder, mental illness, etc.

Design outcomes

Primary

MeasureTime frame
Incidence of sleep disorder on the night of operation;

Secondary

MeasureTime frame
AIS score;Objective sleep data of Fibit charge 2;PSQI score;NRS score;The incidence of delirium ;Subjective sleep rating;Postoperative recovery quality score;

Countries

China

Contacts

Public ContactLinlin Zhao

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University

lin1675@163.com+86 181 6877 7313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 15, 2026